Deep Learning Based HPV Status Prediction for Oropharyngeal Cancer Patients.
HPV status
deep learning
machine learning
oropharyngeal cancer
transfer learning
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
13 Feb 2021
13 Feb 2021
Historique:
received:
28
01
2021
revised:
07
02
2021
accepted:
09
02
2021
entrez:
6
3
2021
pubmed:
7
3
2021
medline:
7
3
2021
Statut:
epublish
Résumé
Infection with the human papillomavirus (HPV) has been identified as a major risk factor for oropharyngeal cancer (OPC). HPV-related OPCs have been shown to be more radiosensitive and to have a reduced risk for cancer related death. Hence, the histological determination of HPV status of cancer patients depicts an essential diagnostic factor. We investigated the ability of deep learning models for imaging based HPV status detection. To overcome the problem of small medical datasets, we used a transfer learning approach. A 3D convolutional network pre-trained on sports video clips was fine-tuned, such that full 3D information in the CT images could be exploited. The video pre-trained model was able to differentiate HPV-positive from HPV-negative cases, with an area under the receiver operating characteristic curve (AUC) of 0.81 for an external test set. In comparison to a 3D convolutional neural network (CNN) trained from scratch and a 2D architecture pre-trained on ImageNet, the video pre-trained model performed best. Deep learning models are capable of CT image-based HPV status determination. Video based pre-training has the ability to improve training for 3D medical data, but further studies are needed for verification.
Identifiants
pubmed: 33668646
pii: cancers13040786
doi: 10.3390/cancers13040786
pmc: PMC7917758
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
PLoS One. 2016 Dec 29;11(12):e0166550
pubmed: 28033372
N Engl J Med. 2001 Apr 12;344(15):1125-31
pubmed: 11297703
Br J Radiol. 2018 Jun;91(1086):20170498
pubmed: 29451412
Acta Oncol. 2015;54(9):1423-9
pubmed: 26264429
Sci Data. 2018 Sep 04;5:180173
pubmed: 30179230
Transl Oncol. 2014 Feb 01;7(1):88-93
pubmed: 24772211
EBioMedicine. 2019 Oct;48:332-340
pubmed: 31522983
EBioMedicine. 2019 Jul;45:70-80
pubmed: 31255659
Eur Arch Otorhinolaryngol. 2017 Jul;274(7):2675-2683
pubmed: 28285422
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
JAMA. 2014 Jan 8;311(2):183-92
pubmed: 24399557
Sci Rep. 2017 Apr 3;7(1):588
pubmed: 28373718
Eur J Nucl Med Mol Imaging. 2020 Dec;47(13):2968-2977
pubmed: 32468251
Clin Cancer Res. 2011 Oct 1;17(19):6262-71
pubmed: 21969383
Lancet Glob Health. 2016 Sep;4(9):e609-16
pubmed: 27470177
Acta Oncol. 2017 Nov;56(11):1544-1553
pubmed: 28885084
J Clin Oncol. 2017 Feb 10;35(5):490-497
pubmed: 28029303
Oral Oncol. 2014 Oct;50(10):942-6
pubmed: 25096827
Oral Oncol. 2013 Oct;49(10):e33-7
pubmed: 23962789
Phys Med Biol. 2017 Aug 01;62(16):R179-R206
pubmed: 28657906
Radiother Oncol. 2019 Jun;135:187-196
pubmed: 30961895
CA Cancer J Clin. 2017 Mar;67(2):122-137
pubmed: 28128848
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
Front Oncol. 2016 Jun 14;6:149
pubmed: 27379211
Oral Oncol. 2014 Sep;50(9):771-9
pubmed: 24932529
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):1107-1116
pubmed: 29506884
Eur J Radiol. 2020 May;126:108936
pubmed: 32171912
Sci Rep. 2020 Mar 11;10(1):4542
pubmed: 32161279
Magn Reson Imaging. 2012 Nov;30(9):1234-48
pubmed: 22898692
Sci Rep. 2017 Aug 31;7(1):10117
pubmed: 28860628
J Natl Cancer Inst. 2000 May 3;92(9):709-20
pubmed: 10793107
Head Neck. 2008 Jul;30(7):898-903
pubmed: 18383529
Sci Rep. 2018 Aug 29;8(1):13047
pubmed: 30158540
Radiother Oncol. 2016 Aug;120(2):258-66
pubmed: 27296412
Radiology. 2018 Mar;286(3):800-809
pubmed: 29309734
Am J Surg Pathol. 2012 Jul;36(7):945-54
pubmed: 22743284
Adv Radiat Oncol. 2019 Feb 23;4(2):413-421
pubmed: 31011687
Nat Biotechnol. 2007 Jun;25(6):675-80
pubmed: 17515910
Recent Results Cancer Res. 2020;216:773-794
pubmed: 32594406
Clin Cancer Res. 2003 Dec 15;9(17):6469-75
pubmed: 14695150